ダウンロード可能なインタラクティブOGEA-103テストエンジン

Enterprise Architectureの基礎準備資料問題集には、Enterprise Architecture OGEA-103試験を受けるために必要なすべての材料が含まれています。詳細は、正確で論理的なものを作成するために業界の経験を常に使用しているEnterprise Architecture によって研究と構成されています。

OGEA-103試験の品質と価値

JPNTestのEnterprise Architecture OGEA-103模擬試験問題集は、認定された対象分野の専門家と公開された作成者のみを使用して、最高の技術精度標準に沿って作成されています。

あなたのOGEA-103試験合格を100%保証

JPNTestテスト問題集を初めて使用したときにEnterprise Architecture OGEA-103試験（TOGAF Enterprise Architecture Combined Part 1 and Part 2 Exam）に合格されなかった場合は、購入料金を全額ご返金いたします。

JPNTestでThe Open Group OGEA-103問題集をチョイスする理由

JPNTestは、1週間で完璧に認定試験を準備することができる、忙しい受験者に最適な問題集を提供しております。 OGEA-103の問題集は、The Open Groupの専門家チームがベンダーの推奨する授業要綱を深く分析して作成されました。弊社のOGEA-103学習材料を一回のみ使用するだけで、The Open Group認証試験に合格することができます。

OGEA-103はThe Open Groupの重要な認証であり、あなたの専門スキルを試す認定でもあります。受験者は、試験を通じて自分の能力を証明したいと考えています。 JPNTest TOGAF Enterprise Architecture Combined Part 1 and Part 2 Exam は、Enterprise Architectureの110の問題と回答を収集して作成しました。TOGAF Enterprise Architecture Combined Part 1 and Part 2 Examの知識ポイントをカバーし、候補者の能力を強化するように設計されています。 JPNTest OGEA-103受験問題集を使用すると、TOGAF Enterprise Architecture Combined Part 1 and Part 2 Examに簡単に合格し、The Open Group認定を取得して、The Open Groupとしてのキャリアをさらに歩むことができます。

デモをダウンロードする

OGEA-103の迅速なアップデート対応

OGEA-103試験に変更がございました場合は、現在の試験と一致するよう、瞬時に学習資料を更新することができます。弊社は、お客様に最高、最新のThe Open Group OGEA-103問題集を提供することに専念しています。なお、ご購入いただいた製品は365日間無料でアップデートされます。

The Open Group TOGAF Enterprise Architecture Combined Part 1 and Part 2 認定 OGEA-103 試験問題:

1. Please read this scenario prior to answering the question
You are serving as the Lead Architect for an Enterprise Architecture team within a leading multinational biotechnology company. The company works in three major industries, including healthcare, crop production, and agriculture. Your team works within the healthcare division.
The healthcare division is developing a new vaccine, and has to demonstrate its effectiveness and safety in a set of clinical trials that satisfy the regulatory requirements of the relevant health authorities. The clinical trials are undertaken by its research laboratories at multiple facilities worldwide. In addition to internal research and development activities, the healthcare division is also involved in publicly funded collaborative research projects with industrial and academic partners.
The Enterprise Architecture team has been engaged in an architecture project to develop a secure system that will allow the healthcare researchers to share information more easily about their clinical trials, and work more collaboratively across the organization and also with its partners. This system will also connect with external partners.
The Enterprise Architecture team uses the TOGAF ADM with extensions required to support healthcare manufacturing practices and laboratory practices. Due to the highly sensitive nature of the information that is managed, special care has been taken to ensure that each architecture domain considers the security and privacy issues that are relevant.
The Vice President for Worldwide Clinical Research is the sponsor of the Enterprise Architecture activity. She has stated that disruptions must be minimized for the clinical trials, and that the rollout must be undertaken incrementally.
Refer to the scenario
You have been asked to recommend the approach to identify the work packages for an incremental rollout meeting the requirements.
Based on the TOGAF standard which of the following is the best answer?

A) You recommend that the Solution Building Blocks from a Consolidated Gaps, Solutions and Dependencies Matrix be grouped into a set of work packages. Using the matrix as a planning tool, regroup the work packages to account for dependencies. Sequence the work packages into the Capability Increments needed to achieve the Target Architecture, so that the implementation team can schedule the rollout one region at a time to minimize disruption. Document the work packages for the Enterprise Architecture using a Transition Architecture State Evolution Table.
B) You recommend that the set of required Solution Building Blocks be determined by identifying those which need to be developed and which need to be procured. Eliminate any duplicates. Group the remaining Solution Building Blocks together to create the work packages using a CRUD (create, read, update, delete) matrix. Rank the work packages and select the most cost-effective options for inclusion in a series of Transition Architectures. Schedule the roll out of the work packages to be sequential across the geographic regions.
C) You recommend that a Consolidated Gaps. Solutions and Dependencies Matrix is used as a planning tool for creating work packages. For each gap classify whether the solution is either a new development, purchased solution, or based on an existing product. Group the similar solutions together to define the work packages. Regroup the work packages into a set of Capability Increments to transition to the Target Architecture considering the schedule for clinical trials, and document in an Architecture Definition Increments Table.
D) You recommend that an Implementation Factor Catalog is drawn up to indicate actions and constraints. A Consolidated Gaps. Solutions and Dependencies Matrix should also be created. For each gap. identify a proposed solution and classify it as new development, purchased solution, or based on an existing product. Group similar activities together to form work packages. Identify dependencies between work packages factoring in the clinical trial schedules. Regroup the work packages into a set of Capability Increments scheduled into a series of Transition Architectures.

2. What is an objective of the ADM Preliminary Phase?

A) To develop a vision of the business value to be delivered by the proposed enterprise architecture
B) To obtain approval for the Statement of Architecture Work
C) To create the initial version of the Architecture Roadmap
D) To select and implement tools to support the Architecture Capability

3. Complete the sentence. When considering agile development, Architecture to Support Portfolio will identify what products the Enterprise needs, the boundary of the products, and what constraints a product owner has; this defines the Enterprise's

A) business continuity
B) operating model
C) risk tolerance
D) backlog

4. What is presented as "striking a balance between positive and negative outcomes resulting from the realization of either opportunities or threats?

A) Agile development
B) Architecture Security
C) Risk Management
D) Transition Management

5. Consider the following statement:
According to the TOGAF Standard a governed approach of a particular deliverable will ensure a system of continuous monitoring to check integrity changes decision-making and audit of all architecture-related activities Which deliverable is being referred to?

A) The Architecture Vision
B) The Statement of Architecture Work
C) An Architecture Contract
D) The Architecture Definition Document

質問と回答：